Ilex Medical Ltd (TLV:ILX)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
6,573.00
+63.00 (0.97%)
Mar 27, 2025, 5:24 PM IDT
5.49%
Market Cap 708.76M
Revenue (ttm) 982.96M
Net Income (ttm) 54.81M
Shares Out 11.28M
EPS (ttm) 4.90
PE Ratio 12.83
Forward PE n/a
Dividend 1.36 (2.07%)
Ex-Dividend Date Apr 7, 2024
Volume 2,704
Average Volume 2,108
Open 6,510.00
Previous Close 6,510.00
Day's Range 6,435.00 - 6,731.00
52-Week Range 6,054.00 - 8,499.00
Beta -0.15
RSI 34.66
Earnings Date Mar 27, 2025

About Ilex Medical

Ilex Medical Ltd provides healthcare technological solutions in Israel, South Africa, and internationally. The company offers microbiology, chemistry, molecular biology, immunochemistry, and blood banking solutions. It also offers coagulation, hematology, blood gases, bilirubin, biomarkers, fertility, cellular medicine occult blood, and calprotectin services, as well as provides LIS, urine microscopy, osmolarity, and genetic laboratory services. In addition, the company offers medical automation solutions for microbiology, immunoserology, chemi... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1977
Employees 223
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol ILX
Full Company Profile

Financial Performance

In 2023, Ilex Medical's revenue was 930.89 million, an increase of 6.69% compared to the previous year's 872.54 million. Earnings were 50.89 million, a decrease of -50.17%.

Financial Statements

News

There is no news available yet.